Susan
Vice President
medical
Viveve
Australia
Biography
Susan joined Viveve in August of 2015 as Vice President of Global Marketing. She brings decades of experience in launching and building new categories of medical devices for novel, elective consumer-driven health and wellness brands. Susan led the marketing effort for Ulthera, the first-ever FDA-cleared procedure for non-invasive skin lifting and tightening — from inception in 2006 with 3 employees to 120 employees 6 years later and subsequent acquisition by Merz Aesthetic for $600 million. Prior to that she contributed to launching firsts in laser hair removal and laser skin resurfacing/rejuvenation (Coherent/Lumenis), radio frequency and infrared technologies for medical aesthetics (Thermage/Solta and Cutera), a time-release technology for a flagship topical pharmaceutical (Johnson & Johnson/Ortho Pharmaceuticals’ Retin-A brand), a diagnostic for detecting and monitoring osteoporosis/bone resorption (Edelman Public Relations) and the concept, innovative at the time, of in-office dispensing of pharmaceuticals and skin care (Summacare, Inc.). Her career in medical devices began as a member of the team that launched the first aesthetic medical device, an injectable for wrinkles and acne scars (Collagen Corporation/Inamed), which pioneered direct-to-consumer marketing of an FDA-cleared device. Other healthcare-related work was with Genentech (a commercialization optimization initiative) and Stanford’s Packard Children’s Hospital (Director of Community Affairs). Susan’s first job after graduating from the University of California at Berkeley was at Stanford University School of Medicine managing the research activities and publication efforts around ground-breaking advances in medical dermatology.
Research Interest
medical